GERN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Geron (GERN) Earnings Date & Reports

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

GERN is expected to report earnings to fall 3.00% to -3 cents per share on May 12

Q1'25

Est.

$-0.04

Q4'24

Missed

by $0.01

Q3'24

Beat

by $0.04

Q2'24

Est.

$-0.10

Q1'24

Beat

by $0.03

The last earnings report on February 26 showed earnings per share of -3 cents, missing the estimate of -2 cents. With 3.57M shares outstanding, the current market capitalization sits at 1.12B.

View a ticker or compare two or three

Compare

GERN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For GERN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of therapeutic products for cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

919 East Hillsdale Boulevard

Phone

+1 650 473-7700

Employees

141

Web

https://www.geron.com